review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.MOLMED.2005.01.005 |
P698 | PubMed publication ID | 15760768 |
P2093 | author name string | Patrick Y Lu | |
Frank Y Xie | |||
Martin C Woodle | |||
P2860 | cites work | TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells | Q24301702 |
TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor | Q24302424 | ||
Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases | Q24311877 | ||
Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC | Q24316380 | ||
Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis | Q24329055 | ||
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle | Q24560011 | ||
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
PINCH-1 Is an Obligate Partner of Integrin-linked Kinase (ILK) Functioning in Cell Shape Modulation, Motility, and Survival | Q28208706 | ||
Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV | Q28247378 | ||
The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration | Q28250994 | ||
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro | Q28259748 | ||
Expression profiling reveals off-target gene regulation by RNAi | Q29615965 | ||
Activation of the interferon system by short-interfering RNAs | Q29620341 | ||
Basement membranes: structure, assembly and role in tumour angiogenesis | Q29622882 | ||
DIP (mDia interacting protein) is a key molecule regulating Rho and Rac in a Src-dependent manner | Q30555216 | ||
Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. | Q30944070 | ||
Clinical translation of angiogenesis inhibitors | Q34152769 | ||
Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. | Q34206478 | ||
PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor | Q34227481 | ||
ILKAP regulates ILK signaling and inhibits anchorage-independent growth | Q34301995 | ||
Lymphangiogenesis and cancer metastasis | Q34770288 | ||
Gene silencing in mammals by small interfering RNAs | Q34931992 | ||
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis | Q35103511 | ||
siRNA-mediated antitumorigenesis for drug target validation and therapeutics. | Q35180667 | ||
Pharmaceutical prospects for RNA interference. | Q35675699 | ||
Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. | Q38347930 | ||
CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells | Q38350055 | ||
Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro. | Q39887642 | ||
Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus | Q40534160 | ||
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis | Q40541706 | ||
Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system | Q40544030 | ||
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics | Q40554467 | ||
RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation | Q40606546 | ||
The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress | Q40615412 | ||
Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression | Q40615471 | ||
RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. | Q40624379 | ||
Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells | Q40653427 | ||
Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells | Q40656821 | ||
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment | Q40725945 | ||
Absence of adhesion triggers differential FAK and SAPKp38 signals in SW620 human colon cancer cells that may inhibit adhesiveness and lead to cell death | Q43924853 | ||
Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. | Q44043660 | ||
RNA interference may be more potent than antisense RNA in human cancer cell lines | Q44287642 | ||
Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis | Q44502162 | ||
The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged | Q44526089 | ||
Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro | Q44564083 | ||
Use of RNA interference to inhibit integrin (alpha6beta4)-mediated invasion and migration of breast carcinoma cells | Q44642910 | ||
Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein | Q44673718 | ||
Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling | Q44709429 | ||
Regulation of tumor angiogenesis by integrin-linked kinase (ILK). | Q44746334 | ||
Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B. | Q44802905 | ||
Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells | Q44814597 | ||
c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components | Q44816472 | ||
Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis | Q44827452 | ||
IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation. | Q44951935 | ||
Cyclic strain-induced endothelial MMP-2: role in vascular smooth muscle cell migration | Q44953572 | ||
VEGF gene polymorphisms and susceptibility to rheumatoid arthritis | Q47301767 | ||
Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells | Q47364895 | ||
Involvement of 3-phosphoinositide-dependent protein kinase-1 in the MEK/MAPK signal transduction pathway | Q47400542 | ||
siRNA agents inhibit oncogene expression and attenuate human tumor cell growth | Q47435082 | ||
Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells. | Q47808941 | ||
Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab. | Q47852768 | ||
Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis | Q47941172 | ||
Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis. | Q51051039 | ||
SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. | Q53923164 | ||
Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma Cells | Q63432724 | ||
Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway | Q73806599 | ||
Lack of interferon response in animals to naked siRNAs | Q81042789 | ||
P433 | issue | 3 | |
P304 | page(s) | 104-113 | |
P577 | publication date | 2005-03-01 | |
P1433 | published in | Trends in Molecular Medicine | Q15265842 |
P1476 | title | Modulation of angiogenesis with siRNA inhibitors for novel therapeutics | |
P478 | volume | 11 |
Q33329034 | Analysis of siRNA specificity on targets with double-nucleotide mismatches |
Q92354274 | Antiangiogenic properties of nanoparticles: a systematic review |
Q39564323 | Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression |
Q37120441 | Delivering small interfering RNA for novel therapeutics |
Q34149828 | Efficient and targeted delivery of siRNA in vivo |
Q37589238 | Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cells |
Q36804396 | Genetic association meets RNA interference: large-scale genomic screens for causation and mechanism of complex diseases |
Q44791097 | Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of Ras. |
Q36396538 | Harnessing in vivo siRNA delivery for drug discovery and therapeutic development |
Q36226774 | In vivo application of RNA interference: from functional genomics to therapeutics |
Q35747541 | Inhibition of human immunodeficiency virus replication by cell membrane-crossing oligomers |
Q37855818 | Leveraging therapeutic potential of multi-targeted siRNA inhibitors |
Q38772275 | Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis |
Q37481329 | RNA interference as an anticancer therapy: a patent perspective |
Q36840109 | RNA interference-mediated gene silencing in murine T cells: in vitro and in vivo validation of proinflammatory target genes |
Q34225712 | RNA interference-mediated gene silencing of vascular endothelial growth factor in colon cancer cells |
Q36311494 | RNA interference: ready to silence cancer? |
Q36199753 | Silence of the transcripts: RNA interference in medicine |
Q36015790 | Silencing of Rac1 expression via RNA interference inhibits retinal neovascularization in rats. |
Q36237868 | The therapeutic potential of RNA interference |
Q88965519 | Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers |
Q38242397 | Therapeutic potential of siRNA and DNAzymes in cancer. |